A kind of glycopeptide with antidepressant function and its preparation method and application
An antidepressant and glycopeptide technology, applied in the biological field, can solve problems such as sexual dysfunction and cognitive impairment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Embodiment 1, preparation of ganoderma lucidum glycopeptide (glycopeptide PGL)
[0045] 1. Preparation of Crude Extract
[0046]Add Ganoderma lucidum spore powder to deionized water, the mass ratio of Ganoderma lucidum spore powder to deionized water is 1:40, extract at 90°C for 4 hours, repeat the extraction three times, and combine the extracts to obtain Ganoderma lucidum water extract. Use the Seveage method to remove the protein in the water extract of Ganoderma lucidum to obtain an extract that removes the protein. The specific method is as follows: Sevag reagent that is 1 / 3 volume of the water extract of Ganoderma lucidum (by chloroform and n-butanol according to the volume of 4:1 (formed by mixing) into the water extract of Ganoderma lucidum, vortexed for 5 minutes, centrifuged at 4500g for 15 minutes, absorbed the supernatant, and removed the gelatinous precipitate produced by the free protein. Add Sevag reagent which is 1 / 3 of the volume of the supernatant to ...
Embodiment 2
[0100] Example 2. Glycopeptide PGL has antidepressant function
[0101] 1. Evaluation of anti-acute depression function
[0102] Male C57BL / 6 mice (8 weeks old, weighing 22-28 g) were purchased from Shanghai Slack Experimental Animals Co., Ltd., and the animals started the experiment after a one-week adaptation period. Mice were randomly divided into 5 groups, 10 animals in each group, respectively blank control group, 100mg / kg PGL group, 200mg / kg PGL group, 400mg / kg PGL group and positive control group. Each mouse in the 100mg / kg PGL group was intragastrically administered the glycopeptide PGL of Example 1 so that the dosage of the glycopeptide PGL was 100mg / kg body weight; each mouse in the 200mg / kg PGL group was administered once a time The glycopeptide PGL of Example 1 was administered intragastrically, so that the dosage of the glycopeptide PGL was 200 mg / kg body weight; each mouse in the 400 mg / kg PGL group was intragastrically administered the glycopeptide PGL of Examp...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com